Soluble thrombomodulin - A molecular marker of endothelial cell injury in children and adolescents with obesity;Rozpuszczalna trombomodulina - Marker uszkodzenia śró dbłonka u dzieci i młodzieży z otyłościa̧ prosta̧

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 11, Issue 2, 2005, Pages 73-77

  Urban, Mirosława ^a   Wojtkielewicz, Katarzyna ^a   Glowińska, Barbara ^a   Peczyńska, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children; Obesity; sTM

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; CHOLESTEROL; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; MOLECULAR MARKER; THROMBIN; THROMBOMODULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING SITE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATININE CLEARANCE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MALE; OBESITY; PATHOGENESIS; ARTERIOSCLEROSIS; BLOOD; BODY MASS; CASE CONTROL STUDY; METABOLISM; RISK FACTOR;

ADOLESCENT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS; THROMBOMODULIN;

EID: 21344460500     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aso Y., Fujiwara Y., Tayama K. i wsp.: Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrom in type 2 diabetes: a comparison with von Willebrand factor. Exp. Clin. Endocrinol. Diab., 2001, 109, 210.
2. Blann A., Farrell A., Picton A., McCollum C.N.: Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb. Res., 2000, 97, 209.
3. Califano F., Giovanniello T., Pantone P. i wsp.: Clinical importance of thrombomodulin serum levels. Eur. Rev. Med. Pharmacol. Sci., 2000, 4, 59.
4. Constans J., Blann A.D., Renard M. i wsp.: Soluble thrombomodulin in hypercholesterolaemic patiens. Lancet, 2000, 355, 145.
5. Cybulska B.: Makroskładniki. [w:] Patofizjologia. red. S. Maśliński, J. Ryżewski. PZWL, Warszawa 1992, 337.
6. Dohi Y, Ohashi M., Sugiyama M. i wsp.: Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens. Res., 2003, 26, 479.
7. Han H.S., Wu H.L., Lin B.T., i wsp.: Effect of thrombomodulin on plasminogen activation. Fibrynol. Proteol., 2000, 14, 221.
8. Komatsumoto S., Onoda A., Nara M.: Changes in the level of thrombomodulin with aging. Nippon Ronen Igakkai Zasshi, 1996, 33, 512.
9. Marckmann P., Nawroth P., Wahl P., Jaspersen J.: Diet, gender, and plasma thrombomodulin. Thromb. Res., 1996, 439.
10. Pearson J.D.: Endothelial cell function and thrombosis. Bailliere's Clin. Haematol., 1999, 329.
11. Porreca E., Di Febbo C., Fusco L. i wsp.: Soluble thrombomodulin and vascular adhesion molecule 1 are associated to leptin plasma levels in obese women. Atherosclerosis, 2004, 172, 175.
12. Rigla M., Fontcuberta J., Mateo J. i wsp.: Physical training decreases plasma thrombomodulin in type I and type II diabetic patients. Diabetologia, 2001, 44, 693.
13. Reinehr T., Andler W.: Changes in the atherogenic risk factor profile according to degree of weight loss. Arch. Dis. Child., 2004, 89, 419.
14. Rose D., Drewniak W., Kinasz-Różycka I. i wsp.: Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men. Pol. Merk. Lek., 2003, 15, 518.
15. Schumacher A., Seljeflot I., Sommervoll L. i wsp.: Increased levels of endothelial haemostatic markers in patients with coronary heart disease. Thromb. Res., 2002, 1, 25.
16. Shimada K., Miyazaki T., Daida H.: Adiponectin and atherosclerosis disease. Clin. Chim. Acta, 2004, 344, 1.
17. Szczygielska A., Widomska A., Jaraszkiewicz M. i wsp.: Bloodlipids profile in obese or overweight patients. Ann. Univ. Mariae Curie Sklodowska. 2003, 58, 343.
18. Veikko S., Matei C., Aleksic N., Sansores-Garcia L., Folsom A.R., Juneja H.: Soluble thrombomodulin as a predictor of incident coronary heart didease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet, 1999, 353, 1729.
19. Viikari J.: Are our children fit or fat? Acta Paediatr., 2004, 93, 306.
20. Woo K.S., Chook P., Yu C.W. i wsp.: Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int. J. Obes. Relat. Metab. Disord., 2004.
21. Wu K.K., Aleksic N., Ballantyne C.M. i wsp.: Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting rise of coronary heart disease. Circulation, 2003, 107, 1729.
22. Yoshii Y., Okada Y., Sasaki S. i wsp.: Expression of thrombomodulin in human aortic smooth muscle cells with special reference to atherosclerotic lesion types and age differences. Med. Electron. Microsc., 2003, 36, 165.